Tirzepatide versus Semaglutide- Surmount-5 trial reveals head-on comparison results Dr. Prem Aggarwal5 Dec 2024 12:00 PM ISTUS: Sharing the topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial, Eli Lilly and Company announced that participants...
West Pharma Raises 2024 Profit Forecast Amid Surging Demand for Injectable Therapy Supplies MD Bureau27 Oct 2024 9:45 AM ISTBengaluru: West Pharmaceutical Services raised its annual profit outlook on Thursday after exceeding Wall Street's expectations for quarterly...
Eli Lilly sues vendors for selling copy of its popular weight loss drug Zepbound MD Bureau22 Oct 2024 3:12 PM ISTLilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products claiming to contain...
Eli Lilly invests $1.8 bln in Ireland sites to scale up Alzheimer's, obesity drug production MD Bureau Team15 Sept 2024 9:00 AM ISTLondon: Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular obesity drug and...
WHO, Eli Lilly warn against fake versions of popular weight loss, diabetes drugs Ruchika Sharma22 Jun 2024 4:46 PM ISTGeneva: The World Health Organization (WHO) and pharmaceutical company Eli Lilly and Co. are cautioning the public about fake versions of popular...
GLP-1 receptor agonist drugs effective but come with complex concerns shows Research Dr. Kamal Kant Kohli12 Jun 2024 8:45 AM ISTDrugs like Ozempic, Wegovy and Mounjaro have been around for years, but they've recently been making headlines due to a rise in popularity as weight...
Cipla open to collaborate with Eli Lilly to market its obesity drugs in India: CEO Ruchika Sharma11 May 2024 11:30 AM ISTBengaluru: The CEO of Cipla on friday expressed openness to collaborate with U.S. pharmaceutical company Eli Lilly for the marketing of their...
Tirzepatide consistently reduces bodyweight regardless of BMI before treatment, shows new analysis Dr. Kamal Kant Kohli25 March 2024 9:30 PM ISTTirzepatide, a medication authorised to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardless of the patient's body mass...
Eli Lilly finds bacteria, other impurities in Mounjaro, Zepbound knockoffs Ruchika Sharma8 March 2024 5:48 PM ISTEli Lilly said on Thursday it has found bacteria and high levels of impurities in products claiming to be compounded versions of tirzepatide, the...
Eli Lilly expects to launch diabetes drug Mounjaro in India next year: CEO Ruchika Sharma29 Feb 2024 12:30 PM ISTMounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the same brand name for both conditions.
EU drug regulator to review use of Eli Lilly Mounjaro in multi-dose pen Ruchika Sharma20 Feb 2024 1:30 PM ISTFrankfurt: The European Union's healthcare regulator will this week review the use of Eli Lilly's approved Mounjaro drug against diabetes and...
Ozempic side effects lawsuit can move forward Ruchika Sharma10 Dec 2023 12:30 PM ISTA Louisiana federal judge on Friday largely rejected Novo Nordisk’s bid to dismiss one of the earliest lawsuits brought against the pharmaceutical...
